Aglaris Ltd
Aglaris specializes in advancing gene and cell therapies by addressing manufacturing challenges. They focus on providing confident quality, consistency, and scalability in cell-based therapies with their innovative bioreactor Facer 1.0. The company is committed to technological progress and enhancing customer experience, with plans to expand their website and services.
Industries
Nr. of Employees
small (1-50)
Products
Bioreactor system for cell-based therapy manufacturing (prototype product)
A bioreactor platform developed to address quality, consistency, and scalability challenges in the manufacturing of cell-based therapies.
FACER
An advanced automated bioreactor designed for scalable cell therapy manufacturing, supporting the production of personalized cell therapies, CAR-T cells, and autologous cell therapies in hospital and GMP settings.
Culture Cartridges
Single-use, gamma-sterilized, closed cartridges supporting multiple cell types, dual-chamber technology, and perfusion control.
Bioreactor system for cell-based therapy manufacturing (prototype product)
A bioreactor platform developed to address quality, consistency, and scalability challenges in the manufacturing of cell-based therapies.
FACER
An advanced automated bioreactor designed for scalable cell therapy manufacturing, supporting the production of personalized cell therapies, CAR-T cells, and autologous cell therapies in hospital and GMP settings.
Culture Cartridges
Single-use, gamma-sterilized, closed cartridges supporting multiple cell types, dual-chamber technology, and perfusion control.
Services
Provision of a bioreactor platform and associated manufacturing optimization intended to improve quality, consistency, and scalability of cell-based therapy production.
Provision of a bioreactor platform and associated manufacturing optimization intended to improve quality, consistency, and scalability of cell-based therapy production.
Expertise Areas
- Cell therapy manufacturing
- Bioreactor engineering
- Process scale-up for cell-based therapeutics
- Manufacturing quality and reproducibility
Key Technologies
- Bioreactor systems for cell therapy manufacturing
- Process scale-up methodologies for cell production
- Manufacturing quality-control practices for biologics